CastleKnight Management’s TriSalus Life Sciences Warrant TLSIW Stock Holding History
Bought
Maintained
Sold
Other funds holding TLSIW
VI
FVWA
HF
ACM
CAC
WAM
GS
TRCT
CastleKnight Management's TLSIW Position: Q3 2024 in Review
CastleKnight Management sold out of TriSalus Life Sciences Warrant (TLSIW) in Q3 2024, closing a stake of 46,371 shares — an estimated $84.4K sold.
CastleKnight Management first reported a position in TLSIW in Q4 2021 and held it in 10 quarters. The position peaked at $84.4K in Q2 2024. 8 funds tracked by Wall St. Rank hold TLSIW as of Q3 2024.
- CastleKnight Management reported no remaining TriSalus Life Sciences Warrant position as of Q3 2024 after selling out during the quarter.
- CastleKnight Management sold 46,371 TriSalus Life Sciences Warrant shares in Q3 2024, an estimated $84.4K.
- CastleKnight Management first reported a position in TriSalus Life Sciences Warrant in Q4 2021 and held it in 10 quarters.
- CastleKnight Management's TriSalus Life Sciences Warrant position peaked at $84.4K in Q2 2024.
- 8 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q3 2024.
Based on CastleKnight Management's 13F filing for Q3 2024, filed 14 Nov 2024.